DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/4827b7/norway_diabetes_ca) has announced the addition of Global Markets Direct's new report "Norway Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017" to their offering.
“Norway Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017”
Norway Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Norway Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
Scope
- Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub- segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Norway Diabetes Care Devices market.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Norway Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Companies Mentioned:
- F. Hoffmann-La Roche Ltd.
- Sanofi
- Novo Nordisk A/S
- Eli Lilly and Company
- Medtronic, Inc.
- LifeScan, Inc.
- Becton, Dickinson and Company
- Animas Corporation
- Bayer HealthCare AG
- Abbott Laboratories
- Ypsomed Holding AG
- NIPRO CORPORATION
- Terumo Corporation
For more information visit http://www.researchandmarkets.com/research/4827b7/norway_diabetes_ca

